Good morning to you all. Please find enclosed a summary of the breaking small-cap and micro-cap financial news we highlighted on AGORACOM Small Cap TV this morning. It’s March 19th, 2012, and we’ve found 4 great press releases to report on at the open. Another great day for small-cap and micro-cap financial news. To watch the show live every morning at 9:30 AM, visit our front page.

China Botanic Reports First Quarter Fiscal 2012 Results

China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines ("TCM") in China, today announced financial results for the three months ended January 31, 2012.

First Quarter 2012 Highlights

lNet sales increased 24.4% year over year to $28.1 million

lGross profit increased 25.4% to $17.3 million from $13.8 million in the first quarter of fiscal 2011

lGross margin increased to 61.6% from 61.1% in the year ago period

lNet income rose 12.4% to $12.3 million, or $0.33 per diluted share, from $10.9 million, or $0.29 per diluted share, in the first quarter of fiscal 2011

Financial Condition

As of January 31, 2012, China Botanic had cash of approximately $21.4 million and total current assets of approximately $70.6 million. The Company had working capital of approximately $56.9 million on January 31, 2012, as compared to $40.8 million at the fiscal year end of October 31, 2011.

Business Outlook

For fiscal year 2012, China Botanic reaffirms its guidance of revenues of between $91.6 million and $93.1 million, representing an increase of 26% to 28% over fiscal year 2011 revenue of $72.7 million. Revenue growth is expected to be driven largely by sales volume increases from the existing product portfolio. The Company expects net income to be in the range of $32.7 million to $33.2 million

ABOUT CHINA BOTANIC PHARMACEUTICAL INC.

China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang.

Last Trade: 0.7552 Week: 1.82 – 0.70Market Cap: 27.93 Million

McEwen Mining Announces Resource and Reserve Increases at the San Jose Mine in Argentina

McEwen Mining Inc. (NYSE:MUX)(TSX:MUX)

is pleased to announce an updated resource and reserve estimate for the San Jose mine (49%). The San Jose mine had a great 2011. Not only was it the forth-consecutive year that silver and gold resources continued to grow, but it also was the highest yearly production to date, producing 5.9 million ounces silver and 80,000 ounces gold. It is worth noting that the resource and reserve estimates were calculated using conservative metal prices of US$18 per ounce silver and US$1,080 per ounce gold. The estimates were independently audited by P&;E Mining Consultants Inc.

San Jose Mine Resources & Reserve Highlights 2011

--Measured and Indicated silver and gold resources up 47% and 56%

respectively, to 68.6 million ounces silver and 1.04 million ounces gold

(100% basis).

--Measured and Indicated resource grades remain consistent with 2010 at

457 gpt silver (475 gpt silver-2010) and 6.95 gpt gold (6.80 gpt gold-

2010).

--Proven and Probable silver and gold reserves up 5% and 15% respectively,

to 22.3 million ounces silver and 0.344 million ounces gold (100%

basis).

ABOUT McEWEN MINING (www.mcewenmining.com)

The objective of McEwen Mining is to qualify for inclusion in the S&P 500 by 2015 by creating a high growth, low-cost, mid-tier silver producer focused in the Americas.

Last: 3.98Range: 9.44-3.05Market Cap: 545 million

Link to hub

Orvana Announces Operations Update at El Valle-Boinas/Carles Gold/Copper Mine, Northern Spain-Cash Costs Reduced to Less Than $650 Per Ounce

Orvana Minerals Corp. (TSX:ORV),

is pleased to announce, through its wholly-owned subsidiary Kinbauri España S.L.U. ("Kinbauri"), an update of operations for its El Valle-Boinás/Carlés ("EVBC") gold-copper mine in northern Spain.

Production for February was improved over the January production, as shown in the table below.

About Orvana

Orvana is a multi-mine gold and copper producer. Orvana's primary asset is the El Valle/Boinás-Carlés gold-copper Mine in northern Spain. Orvana also owns the Don Mario Mine in Bolivia, where the mining and processing of the copper-gold-silver Upper Mineralized Zone deposit remains in the commissioning stage. Orvana recently announced a feasibility study on its Copperwood copper project in Michigan, USA. Additional information is available at Orvana's website (www.orvana.com).

Last: 0.86Range: 3.57-0.81Market Cap: 117 million

Link to hub

CTD Holdings, Inc. Reports Record Revenues for Fiscal 2011

CTD Holdings, Inc. (OTCQB:CTDH) reported record annual revenues of $1,031,849 for the fiscal year ended December 31st, 2011, a 30% increase over 2010 products sales.

Fiscal 2011 Highlights:

lFor the 12 months ended December 31, 2011, sales consisted of 86% Trappsol products and 14% Aquaplex products.

lSales of Trappsol HPB were $889,000 for the year as compared to $690,000 for 2010, representing an increase of $199,000, or 29%.

lSales of Aquaplex were $143,000 for the year as compared to $103,000 for 2010, representing an increase of $40,000, or 39%.

lAt December 31, 2011, The Company had $815,000 in net operating loss carry forwards that can be used to offset its current and future taxable net income and reduce its income tax liabilities.

lCTD reported net loss of ($98,000) for full year 2011 compared to a net loss of ($38,000) for 2010. CTD's cash and short-term investments was $127,000 as of December 31, 2011, compared to $107,000 as of December 31, 2010.

About the Company:

The CTD Holdings, Inc. Family of Companies manufacture and market Trappsol®and Aquaplex cyclodextrins and cyclodextrin complexes for food, nutrition and pharmaceutical markets. NanoSonic Products, Inc. operates the world's only cGMP pulse drying facility for the production of pharmaceutical grade Aquaplex cyclodextrin complexes. The companies offer a wide variety of cyclodextrin related manufacturing services to its worldwide customers; including custom formulation, manufacturing, and commercial scale supply of pharmaceutical grade cyclodextrin complexes.

Last Trade: 0.18952 Week: 0.204 – 0.054Market Cap: 6.81 Million